BioCentury | Aug 31, 2009
Emerging Company Profile

TauTaTis: Tau now

...at Bayer AG and later at German startup Nadag AG, which was subsequently acquired by Sirenade Pharmaceuticals AG...
BioCentury | Jan 23, 2006
Finance

In and out at Novartis Venture

...CombinatoRx IPO 11/9/05 $155.0 GlycArt M&A (Roche) 7/19/05 $181.5 KuDos (A) M&A (AstraZeneca) 12/23/05 $210.0 Sirenade...
BioCentury | Dec 19, 2005
Company News

KeyNeurotek, Sirenade deal

...Sirenade Pharmaceuticals AG , Munich, Germany Business: Neurology, Cancer, Supply/Service KeyNeurotek acquired Sirenade for an undisclosed sum. Sirenade...
BioCentury | Dec 19, 2005
Finance

Ebb & Flow

...Unwinding Last week, Germany's DVC saw exits for two of its portfolio companies. CNS company Sirenade...
...modest sum of low two-digit millions can be raised through a secondary offering on FSE." Sirenade's...
BioCentury | Dec 14, 2005
Company News

KeyNeurotek acquires Sirenade

...Neurology company KeyNeurotek (Magdeburg, Germany) acquired Sirenade (Munich, Germany). Sirenade , which was founded in 2003...
BioCentury | Oct 18, 2004
Emerging Company Profile

Sirenade: Disentangling Alzheimer's

...prevent or to destroy the plaques that typically accumulate in the brains of AD patients. Sirenade Pharmaceuticals AG...
...with the degradation of tau (see BioCentury, Aug. 27, 2001) . "As a result," said Sirenade...
...should make sense to combine targeting of beta amyloid deposits with strategies for eliminating NFTs." Sirenade...
BioCentury | Oct 18, 2004
Emerging Company Profile

Corporate Profile

Sirenade Pharmaceuticals AG Martinsried, Germany Technology: Kinase platforms and libraries Disease focus: Neurology, pain Clinical status: Phase II Founded: 2003 through the merger of Nadag AG and SiReen AG Corporate partners: Solvay Pharmaceuticals University collaborators:...
BioCentury | Oct 18, 2004
Clinical News

Sirenade preclinical data

...Data were presented at the International Conference on Alzheimer's Disease and Related Disorders in Philadelphia. Sirenade Pharmaceuticals AG...
BioCentury | Oct 4, 2004
Company News

Sirenade AG management update

Sirenade AG , Martinsried, Germany Business: Neurology Hired: Lynn Butler as CEO, formerly director of Swentibold sprl; she replaces interim CEO Pierfausto Seneci, who becomes CSO WIR Staff...
BioCentury | Sep 29, 2004
Company News

Sirenade names Butler CEO

...Neurology company Sirenade (Martinsried, Germany) hired Lynn Butler as CEO. Butler, who previously was director of...
Items per page:
1 - 10 of 18
BioCentury | Aug 31, 2009
Emerging Company Profile

TauTaTis: Tau now

...at Bayer AG and later at German startup Nadag AG, which was subsequently acquired by Sirenade Pharmaceuticals AG...
BioCentury | Jan 23, 2006
Finance

In and out at Novartis Venture

...CombinatoRx IPO 11/9/05 $155.0 GlycArt M&A (Roche) 7/19/05 $181.5 KuDos (A) M&A (AstraZeneca) 12/23/05 $210.0 Sirenade...
BioCentury | Dec 19, 2005
Company News

KeyNeurotek, Sirenade deal

...Sirenade Pharmaceuticals AG , Munich, Germany Business: Neurology, Cancer, Supply/Service KeyNeurotek acquired Sirenade for an undisclosed sum. Sirenade...
BioCentury | Dec 19, 2005
Finance

Ebb & Flow

...Unwinding Last week, Germany's DVC saw exits for two of its portfolio companies. CNS company Sirenade...
...modest sum of low two-digit millions can be raised through a secondary offering on FSE." Sirenade's...
BioCentury | Dec 14, 2005
Company News

KeyNeurotek acquires Sirenade

...Neurology company KeyNeurotek (Magdeburg, Germany) acquired Sirenade (Munich, Germany). Sirenade , which was founded in 2003...
BioCentury | Oct 18, 2004
Emerging Company Profile

Sirenade: Disentangling Alzheimer's

...prevent or to destroy the plaques that typically accumulate in the brains of AD patients. Sirenade Pharmaceuticals AG...
...with the degradation of tau (see BioCentury, Aug. 27, 2001) . "As a result," said Sirenade...
...should make sense to combine targeting of beta amyloid deposits with strategies for eliminating NFTs." Sirenade...
BioCentury | Oct 18, 2004
Emerging Company Profile

Corporate Profile

Sirenade Pharmaceuticals AG Martinsried, Germany Technology: Kinase platforms and libraries Disease focus: Neurology, pain Clinical status: Phase II Founded: 2003 through the merger of Nadag AG and SiReen AG Corporate partners: Solvay Pharmaceuticals University collaborators:...
BioCentury | Oct 18, 2004
Clinical News

Sirenade preclinical data

...Data were presented at the International Conference on Alzheimer's Disease and Related Disorders in Philadelphia. Sirenade Pharmaceuticals AG...
BioCentury | Oct 4, 2004
Company News

Sirenade AG management update

Sirenade AG , Martinsried, Germany Business: Neurology Hired: Lynn Butler as CEO, formerly director of Swentibold sprl; she replaces interim CEO Pierfausto Seneci, who becomes CSO WIR Staff...
BioCentury | Sep 29, 2004
Company News

Sirenade names Butler CEO

...Neurology company Sirenade (Martinsried, Germany) hired Lynn Butler as CEO. Butler, who previously was director of...
Items per page:
1 - 10 of 18